FAMAR

FAMAR Awarded EcoVadis Gold – A Milestone in Our ESG Journey At FAMAR, sustainability is far more than a pillar of our strategy. It is embedded in who we are.   We are proud to announce that FAMAR has achieved the EcoVadis Gold medal at Group level, placing us among the top 5% of companies assessed globally. This prestigious recognition reflects the depth of our commitment to ethical practices, environmental stewardship, and corporate responsibility. This accomplishment is especially meaningful at a time when ESG standards are more demanding than ever, and recognition must be earned through measurable, transparent impact.   FAMAR continues to lead by example, not only delivering high-quality pharmaceutical solutions, but doing so responsibly, driven by purpose and accountability.   To our dedicated teams across the Group, I thank you. This achievement is yours. We are building a future where excellence and sustainability go hand in hand. We extend our appreciation also to our shareholders, customers and suppliers, whose trust and collaboration inspire us to raise the bar and build a more sustainable value chain, together.   Kostas Rengis Group CEO

Exciting first industry visit for ISPE Greece/Cyprus student members! Hosted by COMPASS by FAMAR at FAMAR Anthousa, students explored pharmaceutical manufacturing firsthand and connected with our industry experts. A big thank you to ISPE Greece/Cyprus and our FAMAR teams for making this learning experience possible! #FAMAR #COMPASSbyFAMAR #PharmaceuticalExcellence #ISPE #ISPEGreeceCyprus #PharmaceuticalManufacturing #NextGenPharma

This year's #DCATWeek 2025 was an incredible experience for FAMAR to connect with the global pharmaceutical community through a series of productive one-on-one meetings. These discussions allowed us to exchange insights, explore potential collaborations, and showcase our expertise in development, manufacturing, and innovative service offerings.   We had the pleasure of reconnecting with long-standing partners, strengthening collaborations, and exploring exciting new opportunities that will help drive innovation in the healthcare industry. These meaningful conversations reaffirm our commitment to delivering high-quality solutions that support our partners and patients worldwide.   A huge thank you to everyone who took the time to meet with us – your engagement and discussions inspire us to push boundaries and create impactful solutions together. We look forward to continuing these conversations and seeing you all again at DCAT Week 2026! #FAMAR #DCATWeek2025 #PharmaIndustry #cdmo #Innovation #Manufacturing #RandD #Partnerships

Day 1 at #DCATWeek 2025! The event is officially underway, and the FAMAR team is excited to be back at the Intercontinental Barclay Hotel in New York City!   We look forward to reconnecting with our valued customers, exploring new opportunities, and fostering strong partnerships in the pharmaceutical industry. Let’s make this week productive and impactful! #DCATWeek #DCAT #FAMAR #Pharmaceutical #PharmaEvent #CDMO #NewYorkCity

Join the COMPASS by FAMAR Academy Workshop! Don't miss this 2-day workshop in Athens on Sterile Manufacturing & Contamination Control Strategy, designed to provide practical insights and expert guidance. This hands-on learning experience will take place on April 9-10 at Life Gallery Athens, from 9:00 to 17:00. For details & registration: https://lnkd.in/d3iprd3s #FAMAR #COMPASSbyFAMAR #Annex1 #PharmaTraining #SterileManufacturing #Workshop #Athens #CSCO #CDMO

Last Friday, we were thrilled to welcome students from the Master of Organic Chemistry program at Universidad Autónoma de Madrid to FAMAR’s Alcorcón Business Unit in Madrid, Spain! The visit included insightful presentations, dynamic idea exchanges, and a guided tour of our R&D facilities and manufacturing plant, offering a firsthand look at our cutting-edge pharmaceutical processes. At FAMAR, we are committed to bridging academia and industry through meaningful collaborations that drive innovation and growth. #FAMAR #Madrid #CDMO #Academia #Pharmaceutical #Innovation #RandD #UAM